Sopris Capital Acquires Blackford Analysis to Enhance HealthTech Portfolio
Sopris Capital has acquired Blackford Analysis from Bayer, a leader in AI orchestration for medical imaging. The acquisition strengthens Sopris's healthcare technology platform and aligns with its strategy of end-to-end AI-enabled patient care. Blackford will be integrated into Azra AI, one of Sopris’s top-performing portfolio companies, though it will continue to operate as a separate legal entity in Scotland and the U.S., ensuring no disruption for existing clients. Blackford's platform offers over 130 AI applications from more than 45 vendors, enabling health systems to integrate best-of-breed imaging algorithms without workflow disruptions. The integration with Azra AI allows Sopris to expand its capabilities upstream in patient care, starting at the moment of image capture and analysis. Sopris Capital aims to build a connected healthcare technology ecosystem focused on longitudinal patient management using AI. Both Abinav Sankar from Sopris and James Holroyd from Blackford expressed optimism about accelerating growth and expanding platform reach through this strategic move.
Tickers: $BAYRY
Topics: AI in medical imaging Healthcare technology Private equity investment